<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Science and Innovations in Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Science and Innovations in Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Наука и инновации в медицине</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2500-1388</issn><issn publication-format="electronic">2618-754X</issn><publisher><publisher-name xml:lang="en">FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">626927</article-id><article-id pub-id-type="doi">10.35693/SIM626927</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Human Anatomy</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Анатомия человека</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Correlation between portal hypertension and somatic constitution: rationale behind the concept</article-title><trans-title-group xml:lang="ru"><trans-title>Взаимосвязь портальной гипертензии и соматической конституции: обоснование концепции</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9636-3807</contrib-id><contrib-id contrib-id-type="spin">6641-2708</contrib-id><name-alternatives><name xml:lang="en"><surname>Zharikov</surname><given-names>Yury O.</given-names></name><name xml:lang="ru"><surname>Жариков</surname><given-names>Ю. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate professor of the Department of Human Anatomy and Histology of the Institute of clinical medicine</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент, доцент кафедры анатомии и гистологии человека Института клинической медицины</p></bio><email>dr_zharikov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-5108-6813</contrib-id><name-alternatives><name xml:lang="en"><surname>Voloshin</surname><given-names>Ilia A.</given-names></name><name xml:lang="ru"><surname>Волошин</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student of the Institute of clinical medicine</p></bio><bio xml:lang="ru"><p>студент Института клинической медицины</p></bio><email>petsounds@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7513-1636</contrib-id><name-alternatives><name xml:lang="en"><surname>Maslennikov</surname><given-names>Roman V.</given-names></name><name xml:lang="ru"><surname>Масленников</surname><given-names>Р. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate professor, Department of Internal Medicine, Gastroenterology and Hepatology of the Institute of clinical medicine</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и гепатологии Института клинической медицины</p></bio><email>mmmm00@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2557-5647</contrib-id><name-alternatives><name xml:lang="en"><surname>Gadzhiakhmedova</surname><given-names>Aida N.</given-names></name><name xml:lang="ru"><surname>Гаджиахмедова</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student of the Institute of clinical medicine</p></bio><bio xml:lang="ru"><p>студентка Института клинической медицины</p></bio><email>ai.kidman@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6842-1520</contrib-id><name-alternatives><name xml:lang="en"><surname>Zharikova</surname><given-names>Tatiana S.</given-names></name><name xml:lang="ru"><surname>Жарикова</surname><given-names>Т. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Associate professor of the Department of Human Anatomy and Histology; Associate professor of the Department of normal and topographical anatomy</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент кафедры анатомии и гистологии человека Института клинической медицины; доцент кафедры нормальной и топографической анатомии</p></bio><email>dr_zharikova@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9532-9957</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolenko</surname><given-names>Vladimir N.</given-names></name><name xml:lang="ru"><surname>Николенко</surname><given-names>В. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, PhD, Professor, Head of the Department of Human Anatomy and Histology of the Institute of clinical medicine; Head of the Department of normal and topographical anatomy</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор, заведующий кафедрой анатомии и гистологии человека Института клинической медицины; заведующий кафедрой нормальной и топографической анатомии</p></bio><email>vn.nikolenko@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый МГМУ имени И.М. Сеченова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный университет имени М.В. Ломоносова»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-10-27" publication-format="electronic"><day>27</day><month>10</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2024</year></pub-date><volume>9</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>251</fpage><lpage>255</lpage><history><date date-type="received" iso-8601-date="2024-02-14"><day>14</day><month>02</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-03-12"><day>12</day><month>03</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Zharikov Y.O., Voloshin I.A., Maslennikov R.V., Gadzhiakhmedova A.N., Zharikova T.S., Nikolenko V.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Жариков Ю.О., Волошин И.А., Масленников Р.В., Гаджиахмедова А.Н., Жарикова Т.С., Николенко В.Н.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Zharikov Y.O., Voloshin I.A., Maslennikov R.V., Gadzhiakhmedova A.N., Zharikova T.S., Nikolenko V.N.</copyright-holder><copyright-holder xml:lang="ru">Жариков Ю.О., Волошин И.А., Масленников Р.В., Гаджиахмедова А.Н., Жарикова Т.С., Николенко В.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://innoscience.ru/2500-1388/article/view/626927">https://innoscience.ru/2500-1388/article/view/626927</self-uri><abstract xml:lang="en"><p>Portal hypertension, one of the serious consequences of liver cirrhosis, contributes to the aggravation of complications such as ascites, varicose veins of the esophagus, stomach and anterior abdominal wall, splenomegaly and hepatic encephalopathy.</p> <p>This review article evaluates the biomolecular mechanisms that determine the role of human constitutional characteristics as a prognostic factor for portal hypertension and the course of liver cirrhosis. A search for publications and an analysis of literary sources was conducted using the PubMed and eLibrary.ru databases, mainly for the last 10 years. A search for publications was performed by keywords, as a result of which 6418 works were found (3623 full-text papers), 108 publications were studied, of which 23 publications were referenced.</p> <p>The analysis of papers resulted in the identification of one of the leading biomolecular mechanisms that determine the correlation between the constitutional features of the body, namely, an increased endomorphic component, and the risk of developing portal hypertension. The greatest influence on the endomorphic component of body composition derives from proinflammatory factors, insulin resistance and the absence of insulin sensitization syndrome caused by food intake.</p></abstract><trans-abstract xml:lang="ru"><p>Портальная гипертензия, являющаяся одним из серьезных последствий цирроза печени, способствует усугублению таких осложнений, как асцит, варикозное расширение вен пищевода, желудка и передней брюшной стенки, спленомегалии и печеночной энцефалопатии.</p> <p>В обзорной статье оценены биомолекулярные механизмы, обусловливающие роль конституциональных особенностей человека в качестве прогностического фактора портальной гипертензии и течения цирроза печени. Проведен поиск публикаций и анализ литературных источников с использованием баз данных PubMed и eLibrary.ru преимущественно за последние 10 лет. По ключевым словам выполнен поиск публикаций, в результате которого было обнаружено 6418 работ (3623 из которых полнотекстовые), проведено изучение 108 публикаций, из которых на 23 публикации представлены ссылки.</p> <p>Анализ литературы позволил определить один из ведущих биомолекулярных механизмов, обусловливающих корреляцию конституциональных особенностей организма, а именно увеличенного эндоморфного компонента, и риска развития портальной гипертензии. Наибольшее влияние на эндоморфный компонент состава тела оказывают провоспалительные факторы, инсулинорезистентность и отсутствие синдрома сенсибилизации к инсулину, вызванного приемом пищи.</p></trans-abstract><kwd-group xml:lang="en"><kwd>liver cirrhosis</kwd><kwd>portal hypertension</kwd><kwd>somatic constitution</kwd><kwd>biomolecular pathways</kwd><kwd>risks</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цирроз печени</kwd><kwd>портальная гипертензия</kwd><kwd>соматическая конституция</kwd><kwd>биомолекулярные пути</kwd><kwd>риски</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Zharikov YuO, Maslennikov RV, Gadzhiakhmedova AN, et al. Quantitative analysis of the structure of the portal vein of the liver and splenic vein in people with different somatotypes in portal hypertension. Morphology. 2022;160(3):171-176. [Жариков Ю.О., Масленников Р.В., Гаджиахмедова А.Н., и др. Количественный анализ строения воротной вены печени и селезеночной вены у людей с разными соматотипами при портальной гипертензии. Морфология. 2022;160(3):171-176. DOI: https://doi.org/10.17816/morph.431613</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Zakko A, T Kroner P, Nankani R, Karagozian R. Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients. Gastroenterol Hepatol Bed Bench. 2018;11(2):153-158. PMCID: PMC5990917</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305-13. DOI: https://doi.org/10.1056/NEJMoa020245</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fortea JI, Puente Á, Cuadrado A, et al. Congestive Hepatopathy. Int J Mol Sci. 2020;21(24):9420. DOI: https://doi.org/10.3390/ijms21249420</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc. 2019;94(4):714-726. DOI: https://doi.org/10.1016/j.mayocp.2018.12.020</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kocabayoglu P, Friedman SL. Cellular basis of hepatic fibrosis and its role in inflammation and cancer. Front Biosci (Schol Ed). 2013;5(1):217-30. DOI: https://doi.org/10.2741/s368</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kumar V, Abbas AK, Aster JC. Robbins and Cotran pathologic basis of disease (Ninth edition.). Elsevier/Saunders, 2015:153 ISBN: 9781416031215</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Chang ML, Yang Z, Yang SS. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression. Int J Mol Sci. 2020;21(21):8308. DOI: https://doi.org/10.3390/ijms21218308</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Romacho T, Elsen M, Röhrborn D, Eckel J. Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf). 2014;210(4):733-53. DOI: https://doi.org/10.1111/apha.12246</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Azzu V, Vacca M, Virtue S, et al. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. Gastroenterology. 2020;158(7):1899-1912. DOI: https://doi.org/10.1053/j.gastro.2019.12.054</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Pan X, Wang P, Luo J, et al. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients. Endocrine. 2015;48(3):834-47. DOI: https://doi.org/10.1007/s12020-014-0384-x</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Boutari C, Perakakis N, Mantzoros CS. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. Endocrinol Metab (Seoul). 2018;33(1):33-43. DOI: https://doi.org/10.3803/EnM.2018.33.1.33</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Parthasarathy G, Revelo X, Malhi H. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. Hepatol Commun. 2020;4(4):478-492. DOI: https://doi.org/10.1002/hep4.1479</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Bastard JP, Fève B. The Relationship Among Obesity, Inflammation, and Insulin Resistance. Eur Cytokine Netw. 2013;11(1):4-12. DOI: https://doi.org/10.1002/9781118395318.ch17</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Erice E, Llop E, Berzigotti A, et al. Insulin resistance in patients with cirrhosis and portal hypertension. Am J Physiol Gastrointest Liver Physiol. 2012;302(12):G1458-65. DOI: https://doi.org/10.1152/ajpgi.00389.2011</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Mota M, Banini BA, Cazanave SC, Sanyal AJ. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism. 2016;65(8):1049-61. DOI: https://doi.org/10.1016/j.metabol.2016.02.014</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lee SH, Park SY, Choi CS. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. 2022;46(1):15-37. DOI: https://doi.org/10.4093/dmj.2021.0280</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Lautt WW, Schafer J, Macedo MP, Legare DJ. Bethanechol and N-acetylcysteine mimic feeding signals and reverse insulin resistance in fasted and sucrose-induced diabetic rats. Can J Physiol Pharmacol. 2011;89(2):135-42. DOI: https://doi.org/10.1139/y11-001</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Patarrão RS, Lautt WW, Afonso RA, et al. Meal-induced insulin sensitization and its parasympathetic regulation in humans. Can J Physiol Pharmacol. 2008;86(12):880-8. DOI: https://doi.org/10.1139/Y08-080</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Fernandes AB, Patarrão RS, Videira PA, Macedo MP. Understanding postprandial glucose clearance by peripheral organs: the role of the hepatic parasympathetic system. J Neuroendocrinol. 2011;23(12):1288-95. DOI: https://doi.org/10.1111/j.1365-2826.2011.02226.x</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Xie H, Lautt WW. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am J Physiol. 1996;270(5 Pt 1):E858-63. DOI: https://doi.org/10.1152/ajpendo.1996.270.5.E858</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Afonso RA, Gaspar JM, Lamarão I, et al. Postprandial insulin action relies on meal composition and hepatic parasympathetics: dependency on glucose and amino acids: Meal, parasympathetics &amp; insulin action. J Nutr Biochem. 2016;27:70-8. DOI: https://doi.org/10.1016/j.jnutbio.2015.08.023</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Guarino MP, Correia NC, Lautt WW, Macedo MP. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am J Physiol Gastrointest Liver Physiol. 2004;287(3):G527-32. DOI: https://doi.org/10.1152/ajpgi.00085.2004</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Liu YB, Chen MK. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World J Gastroenterol. 2022;28(41):5910-5930. DOI: https://doi.org/10.3748/wjg.v28.i41.5910</mixed-citation></ref></ref-list></back></article>
